These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7186465)

  • 1. [Possibilities and limitations of long-term treatment with rifampicin infusion in tubercular disease].
    Rosetti L; Serra A; Arba GV
    G Ital Chemioter; 1982; 29(2):125-32. PubMed ID: 7186465
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term intravenous rifampicin treatment. Advantages and disadvantages.
    Anker N; Band FC
    Eur J Respir Dis; 1981; 62(2):84-6. PubMed ID: 6453721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic possibilities of inhalation of rifampicin with dimexide in phthisiopulmonology].
    Gorbach IN; Samtsov VS
    Probl Tuberk; 1991; (3):34-6. PubMed ID: 1871090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin].
    Böszörmenyi M
    Gruzlica; 1974 May; 42(5):407-10. PubMed ID: 4464228
    [No Abstract]   [Full Text] [Related]  

  • 5. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of rifampicin applied every other day for severe cavitary pulmonary tuberculosis].
    Hashimoto T; Takahashi S; Kasai K; Tamura M; Yamada M
    Kekkaku; 1972 Aug; 47(8):273-7. PubMed ID: 4660855
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of pulmonary tuberculosis of native Black Africans a chemotherapeutic regime including rifampicin (apropos of 75 patients)].
    Ayad M; Hane A; Kane PA
    Dakar Med; 1980; 25(1):65-74. PubMed ID: 7460740
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relation between the efficacy of complex therapy of patients with destructive pulmonary tuberculosis and the duration of rifampicin administration].
    Sagalovich VIa; Manzhikova SR
    Probl Tuberk; 1984 Oct; (10):51-4. PubMed ID: 6514699
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN; Sedunova EA; Korotaeva TA
    Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
    [No Abstract]   [Full Text] [Related]  

  • 11. [1st observations on the activity of the oral Rifampicin in the treatment of chronic pulmonary tuberculosis].
    Daddi G; Cornia G; Grassi C; Perna G; Scarpazza G
    G Ital Mal Torace; 1967; 21(3):131-6. PubMed ID: 5604472
    [No Abstract]   [Full Text] [Related]  

  • 12. [A clinico-electrophysiologic study of ethambutol and rifampicin during long-term treatment].
    Shmelev NA; Shabalova LN
    Antibiotiki; 1974 Oct; 19(10):932-7. PubMed ID: 4462455
    [No Abstract]   [Full Text] [Related]  

  • 13. [Qualitative reaction for determining rifampicin in the urine for the purpose of controlling patient intake of this preparation].
    Tatarinova NV; Zhuk NA; Chukanov VI
    Probl Tuberk; 1979 Aug; (8):62-5. PubMed ID: 482271
    [No Abstract]   [Full Text] [Related]  

  • 14. [The oral use of rifampicin in 10 cases of chronic pulmonary tuberculosis].
    Soregaroli E; Pozzi M
    G Ital Mal Torace; 1969; ():Suppl 2:14-6. PubMed ID: 5357134
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis].
    Ursov IG; Krasnov VA; B1tashova VA; Kudelia OA; Volkova ZhA; Gromyko NI; Borovinskaia TA
    Probl Tuberk; 1998; (4):21-2. PubMed ID: 9771031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 17. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].
    Eule H; Werner E; Winsel K; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):276-7. PubMed ID: 4011667
    [No Abstract]   [Full Text] [Related]  

  • 18. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of therapeutic effects of rifampicin 450 mg daily and 600 mg three times weekly on the previously treated pulmonary tuberculosis patients].
    Yamamoto M; Mizutani A; Nakamura H; Hirose H; Nagata A
    Kekkaku; 1973 May; 48(5):197-202. PubMed ID: 4732658
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with rifomycin SV by slow venous perfusion in pulmonary tuberculosis].
    Lucchesi M; Pallotta G; Sternini M; Tiraterra M
    Ann Ist Carlo Forlanini; 1965; 25(1):30-46. PubMed ID: 5830576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.